ABSTRACT Plasma lead concentrations were determined in 103 subjects, including lead workers and those not occupationally exposed to lead. The plasma lead concentrations in each blood lead group were about half those previously reported, and this difference was shown to be due to the use of heparin instead of ethylenediaminetetra-acetic acid (EDTA) as the anticoagulant. The method for the determination of lead in plasma is detailed and its accuracy discussed. The plasma lead concentration was found to increase with the erythrocyte lead concentration, the mean equilibrium ratio between the two being about 0.74%. The effect of a sudden disturbance of the equilibrium condition on this ratio was investigated. This work supports the view that whole blood lead concentrations should be corrected for haematocrit.
the two being about 0.74%. The effect of a sudden disturbance of the equilibrium condition on this ratio was investigated. This work supports the view that whole blood lead concentrations should be corrected for haematocrit.
In 1978 Cavalleri et al1 claimed that plasma lead increased progressively and significantly with the increase of whole blood lead, while its relative percentage in the plasma remained practically constant at about 3% (means ranging from 2 9 to 33 3%) for all concentrations in whole blood-that is, (PI = k = 3 % where [P] = the concentration of lead in the plasma and [B] = the concentration of lead in the blood.
This finding is in pronounced contrast to the work of Rosen et al,2 who claimed to have shown that plasma concentrations of lead remain constant over a wide rapge of haematocrit and whole blood lead concentrations-that is, [P] Chamberlain et altl have estimated that less than 03 % of 203Pb present in the blood of three subjects, ten hours after administration, was in the plasma fraction.
The significance of the work of Rosen et at2 lies in the fact that it has been widely quoted by many authorities'2 13 as having provided evidence to support the view that whole blood lead concentrations should not be corrected for haematocrit. This evidence is based on the claim that plasma lead concentrations are maintained "within narrow limits" and that consequently the erythrocytes have an unlimited capacity for the uptake of lead.
This paper reports a series of plasma lead determinations using an almost identical procedure as did Cavalleri et al, but with the important difference that the blood specimens were collected in heparinised tubes instead of EDTA tubes as used by Cavalleri et al. This difference has a very significant effect on the accuracy and scatter of the results obtained. Although they state that the plasma was separated from the red cells "immediately" after collection, they do not emphasise this point and are apparently unaware of its importance. In practice it is impossible to collect blood in EDTA tubes and separate the plasma from the red cells without a significant movement of lead from the red cells to the plasma. It will be shown that, even with the centrifuge at the patient's side, the concentration of lead in the plasma when the blood is collected into EDTA tubes is about twice that when collected into heparinised tubes. It follows that the mean ratio of plasma lead concentration to 209 deSilva whole blood lead concentration was overestimated by Cavalleri et al.
The range and standard deviation of their results in each blood lead group show a larger scatter of results than obtained in this study using heparin tubes. This wider scatter of results is probably also largely due to slight variations in the time taken between the collecting and centrifuging of the blood samples. It is not possible to reduce this time to zero, and there are obvious practical difficulties in making the time uniform, particularly if subjects are being bled in groups.
From a theoretical point of view one would expect that, when a person is in equilibrium, the ratio between the plasma lead concentration [P] There is no theoretical basis for comparing [P] with [B] as done by Cavalleri. Nevertheless, for the purposes of direct comparison with Cavalleri's work some of the results will be presented in terms of this comparison. This paper also reports a short series of blood and plasma lead concentrations on a subject who volunteered to ingest a dose of lead on two separate occasions. The subject was a medical practitioner who has had an interest in lead metabolism for many years and participated with full knowledge of the toxicity of lead. The purpose of this investigation was to establish the period required for the equilibrium to be re-established and to investigate the extent of the increase in the ratio [PI under con- ditions of rapid absorption.
Part I Determination of lead in plasma in lead workers and "unexposed" subjects
SELECTION OF SUBJECTS
The aim was to collect about 100 samples distributed as evenly as possible over the available blood lead range with about 20 subjects for each 20 ,ug/100 ml (0 97 pumol/l) range of whole blood lead concentrations.
The principle source of the samples was the subjects attending the industrial hygiene section for evaluation of their lead state. These subjects include a high proportion of lead workers (about 60 %) whose screening coproporphyrin test, normally carried out on the factory premises, had exceeded 1000 Hug/1 (1530 ,umol/l). In addition, there was a miscellaneous group referred by private medical practitioners, whose lead concentrations were mostly in the normal range. There was, therefore, no difficulty in obtaining specimens in the blood lead ranges under 20 ,ug/100 ml (0-97 ,umol/l) and over 60 Kg/100 ml (2-9 ,umol/l). Between 20 ,g/100 ml (0 97 ,umol/l) and 60 ,ug/100 ml (2-9 umol/l) some difficulty was experienced in obtaining sufficient samples. For this reason, 23 of the 105 samples were obtained by visiting two factories and collecting blood from volunteers whose exposure to lead was moderate.
Thus lead concentrations in plasma were determined in 103 individuals (two results were excluded -see later) with blood lead concentrations ranging from 5 ,ug/100 ml (0-24 ,umol/l) to 109 tg/l100 ml (5 26 ,umol/l). The numbers in each group are shown in table 1. SAMPLE COLLECTION About 12 ml of blood was withdrawn by venepuncture and placed in a heparinised blood collecting tube (see method). About 2 ml of this blood was used for routine blood lead analysis carried out by another analyst, using a carbon rod atomic absorption method with direct application of haemolysed blood to the rod.14 The remaining 10 ml was centrifuged for 20 min at 3500 rpm. As the number of subjects attending the section in any one day was usually under six, the specimens were collected serially and then centrifuged together, resulting in a delay of about 30 min for the first specimen collected. It was shown, however, that no change in plasma lead occurred if the specimens were left in heparinised tubes for up to two hours before separation, and therefore this time was not critical. The 23 specimens collected in two factories could not be centrifuged within 30 min, the first ones collected being subject to a delay of up to two hours before separation.
The plasma was removed and placed in a second tube and centrifuged again. The second centrifuging was considered necessary to ensure that no red cells were left in the plasma fraction. This second tube usually showed a few red cells at the bottom; but the plasma for analysis could be pipetted off the top without disturbing the cells. Duplicate 2 ml aliquots of plasma were pipetted and analysed within 24 hours if possible, but otherwise frozen for later analysis. The whole blood lead determinations were performed routinely on the day of collection.
DESIGN OF THE STUDY
All analyses of plasma lead were carried out blind with respect to the whole blood lead concentration.
Of the 105 samples, 84 were analysed in duplicate, blind with respect to which were the duplicates in each batch. It was considered unreasonable to take duplicate venepuncture samples from each subject, and the duplication therefore starts after the separation of the plasma, and is thus a measure of the reproducibility of the analysis within one batch.
The analyses were performed in batches of 14, consisting of ten tests (usually five subjects in duplicate), three standards, and one blank. This was the maximum number that could be done in half a day, including preparation and atomic absorption work. Each solvent layer was injected a minimum of three times, the exact number of injections depending on their reproducibility.
METHOD
The method employed for the plasma lead determination is based on the chelation solvent-extraction procedure of Hessel15 and is similar to that used by Cavalleri et al.1 It will be presented here in some detail because of the great importance of such factors as accuracy and precision and the prevention of contamination.
Apparatus
All determinations were performed using a varian atomic absorption spectrophotometer (AA-175B) with a varian carbon rod atomiser (CRA-90).
Extreme care was taken to avoid contamination of any of the glassware, centrifuge tubes, or bloodcollecting tubes. Blood-collecting tubes were prepared using polypropylene centrifuge tubes of about 15 ml capacity. Only new tubes were used, and these were washed by soaking overnight, first in detergent and then in 10% nitric acid. They were heparinised by adding 0 1 ml of 1 % aqueous sodium heparin per tube and drying the tubes in the oven. Commercially available heparinised blood-collecting tubes, while quite satisfactory for whole blood lead determination, were found to release about 10 ng of lead to 5 ml of plasma added to the tubes and rotated for 15 minutes, which is equivalent to a plasma lead concentration of 0-20 ,ug/100 ml (0-010 pmol/l).
Whereas this amount of lead is insignificant in relation to a whole blood lead level, it is about equal to the concentration of lead in the plasma of "normal" individuals. The same polypropylene tubes were used for the second centrifugation and also for the reaction vessels.
Blank value A blank determination was performed in every batch as a continuing check on the cleanliness of the apparatus and the purity of the reagents.
All reagents were tested for lead content, the only one with a significant amount being the methyl isobutyl ketone. This could not be removed by distillation and collection of the centre fraction only.
Several batches of methyl isobutyl ketone were tested, and the best was selected. The mean value of the reagent blank (due almost entirely to methyl isobutyl ketone) was equivalent to a plasma lead value of 0-06 pkg/l00 ml (0-003 ,umol/l), and its standard deviation was 0 03 ,tg/100 ml (0-001 ,umol/l).
Using the definitions of detection limit and determination limit proposed by Currie,16 the detection limit of the method is 0 10 ,ug/100 ml (0 005 ,umol/l) and the determination limit is 0 30 pg/100 ml (0-015 ,umol/l), assuming that the maximum acceptable relative standard deviation for quantitative analysis is 10 %; if one is prepared, of necessity, to accept a relative standard deviation of 20 % the determination limit is 015 ,ug/100 ml (0 007 tkmol/l).
Calibration
In the standard chelation solvent-extraction whole blood lead method (flame atomic absorption) it is possible to use aqueous lead solutions to prepare a calibration graph. An attempt was made to use similar standards for the carbon rod method; but a matrix effect was evident, which is apparently not a problem with the flame method. The extent of this matrix effect is shown in fig 1.
It was therefore necessary to use the "standard additions" technique-that is, to prepare calibration graphs by the addition of known amounts of lead to plasma and to determine the amount of lead originally present in the plasma (the "endogenous" lead) by extrapolation.
Two hundred millilitres of plasma was obtained on three occasions from volunteers with no special exposure to lead, pipetted into 2 ml aliquots and frozen. Freezing of the plasma after aliquoting was unavoidable, although it resulted in the separation of the fibrin in each aliquot.
On the day of analysis at least three of these tubes were thawed, and known amounts of lead were added. The standard lead solution contained 0-1 mg Pb/I (0-48 p,mol/l) and was prepared fresh daily from a stock solution containing 10 mg Pb/l (48 ,tmol/l).
Calibration graphs were prepared on each day for each batch of ten analyses. The slope of the calibration graph varied from day to day apparently depending on the instrument conditions; but the sensitivity (that concentration of lead in plasma at which the absorbance equals 0 0044) was never less than 0-06 ,ug/l00 ml (0-0029 ,umol/l) and was usually about 0-03 ,ug/100 ml (0-0014 ,umol/l).
A typical calibration graph is shown in fig 1  ( 
other methods in that there is no difference between a "recovery" and a "standard," except that the recovery is done "blind." There is little opportunity for serious and varied losses of lead such as can occur with procedures entailing the destruction of organic matter by heating and for which recoveries are a valuable means of assessing losses of lead.
The many calibration graphs prepared during preliminary work on the method gave a good indication that the method was accurate provided that "endogenous" lead behaved in the same way as "added" lead. All the points on these graphs fell very closely either on to a straight line or on to a line with a very slight degree of curvature.
It was decided to collect further data on accuracy and precision throughout the conduct of the study rather than as a separate preliminary exercise, as carried out by Cavalleri et al.1 Preliminary estimations of a method's accuracy and precision do not guarantee that the same standards will be maintained throughout the investigation. It should always be regarded as essential to demonstrate the accuracy and precision achieved during the course of any study.
Thus 88 of the 105 analyses were done in blind duplicate. Two of the pairs of duplicates have been excluded because the large differences between them of 060 ,tg/100 ml (0 029,tmol/l) and 0 66 ,tg/100 ml (0-032 ,umol/l) indicate that relatively serious contamination must have occurred. The mean difference between the remaining 86 duplicates was 0-092,ug/100 ml (0 0044 ,umol/l). The distribution of the difference showed that 65 of the 86 duplicates (76%) were <0-14 ,ug/100 ml (0-0068 ,umol/l) apart.
The distribution of the percentage difference showed that 68 of the 86 duplicates (79 %) were < 20 % apart.
For the reasons indicated above, only nine blind recoveries were carried out. For seven of these, the added lead ranged from 0-56 ,ug/100 ml (0-027 ,umol/l) to 1 72,g/100 ml (0-083,mol/l), and a mean recovery of 990% was obtained. For two, the added lead was only 0-06 ,ug/l00 ml (0-0029 ,umol/l) and 0-12 ,ug/100 ml (0-0058 ,umol/l), and recoveries of 500% and 670% respectively were obtained. These results confirm that the limit of detection is about 0-1 ,ag/100 ml (0-0048 ,umol/l) and that accurate results will not be obtained below about 0 3 Pg/100 ml (0-015 ,umol/l).
Two other factors, although not quantifiable, contribute to one's confidence that the method has reliably measured the lead level in plasma. These are:
(a) the demonstration of a highly significant regression coefficient in the regression equation showing the relationship between plasma lead concentration and erythrocyte lead concentration (see "results"), and (b) the results of the in-vivo studies after the ingestion of lead (see part II), which were consistent with theoretical expectations.
While none of the procedures detailed above regarded separately is proof that the method is accurate, together they provide considerable evidence to that effect. Figure 2 is a scattergram of the results of the plasma lead concentration against the erythrocyte lead concentration and illustrates the interdependence of [P] and [E] .* This interdependence cannot be explained by the fact that the value of [P] is used in the calculation of [E] because its contribution to the value of [E] is insignificant.
RESULTS
Because the study sample was contrived and therefore not normally distributed, the correlation coefficient cannot be used to demonstrate the relationship between the two variables. The relationship, however, can be represented by the regression equation y = 0O009 x -0-13 where y = the predicted plasma lead concentration in ,tg/lOO ml, and x = the erythrocyte lead concentration in ,ug/100 ml. The regression coefficient 0 009 is highly significant, its standard error being +00008 (p < 0-001); but the constant is not significantly different from zero (t test). The 95% confidence limits of y about the regression line are + 0 9 ,ug/100 ml (0 044 ,mol/l ,tmol/l), the ratio is 1 2%, which is significantly different at the 2 % level (Wilcoxon two sample rank sum test) from the ratio of 0 74 % (standard deviation 0-31 %) calculated using the results from the 81 subjects in the four intermediate groups with
erythrocyte lead concentrations between 40 ,tg/100 ml (1 9,umol/l) and 199 ,tg/l00 ml (9-6 ,umol/l). The possible reasons for this will be considered in the discussion section. This makes legitimate the application of multiple regression analysis to the results and this analysis yields the following multiple regression equation y = 1-09 + 0-020 xi -0-028 X2 where y = the predicted plasma lead concentration in ,ug/100 ml, xi = the whole blood lead concentration in ,ug/100 ml, and X2 = the haematocrit as a percentage. The partial regression coefficient for the blood lead concentration (0 020) is significant at the 1 % level and for the haematocrit value (-0 028) at the 2% level (t test). If the equation is derived using only those duplicate results under 20% apart, however, the regression coefficient for the haematocrit value is also significant at the 1 % level. The equation using these results is y = 2-11 + 0-020 xi -0049 X2.
It follows from the form of the multiple regression equation (a positive coefficient of xi and a negative coefficient of X2) that
(1) with a constant value of the haematocrit (X2) the plasma lead concentration increases with increase in blood lead concentration and (2) with a constant value of the blood lead concentration (xi) the plasma lead concentration decreases with increase in the haematocrit value. 
Ht
PartII Effect of a sudden intake of lead on the ratio [PI The ratio of plasma lead concentration to erythrocyte lead concentration in any individual may well be constant when the subject is in equilibrium. Significant increases in the ratio, however, may be expected to result from sudden departures from equilibrium which are likely to occur when there is a sudden increase in the subject's exposure to lead. It was therefore decided to investigate a situation where an equilibrium condition was suddenly disturbed.
On two separate occasions, four months apart, a volunteer without any special exposure to lead, ingested 100 mg of lead as lead acetate.
FIRST STUDY (7 August 79) A sample of blood was taken at 6 00 am after which the lead was ingested, the subject having fasted since the previous evening. Blood samples were then taken at two-hourly intervals for the remainder of the day, once on the next day, and occasionally over the next few days. They show that the ratio was 3 2 % two hours after ingestion of lead, about four times the mean ratio expected from the part I study. The higher than average predose ratio of 1P7 is probably due to the greater inaccuracy of both the plasma lead analysis and the whole blood lead analysis at this low level. The ratio fell from 3 2 to 1 1 in 26 hours.
SECOND STUDY (10 December 79) The study was repeated after the blood lead value had returned to normal. The main reason for the repeat study was to reduce the time interval between the first few samples in case the peak concentration had been achieved within the first two hours. The blood lead concentration rose more slowly than in the first study, reaching a peak of only 46 ,ug/100 ml ,umol/l) compared with 78 ,ug/100 ml (3 77 pmol/l), despite the fact that the same dose of lead was given. This may have been due to the fact that the subject's fluid intake was much higher in the second study and slowed down the absorption of lead from the gut. Nevertheless, the ratio rose from 1 0 % to 2-2 %, one hour after ingestion and fell to the predose level of 
Discussion
The plasma lead concentrations in this study are significantly lower than those obtained by Cavalleri et al.1 Table 3 compares the results of this study with theirs. The lower concentrations and somewhat smaller ranges are attributed to the use of heparinised tubes instead of EDTA tubes.
The effect of EDTA on the plasma lead concentration is significant, even when the blood is centrifuged with as little delay as possible. Samples of blood from six subjects were divided into two parts, one part added to a heparin tube and the other part to an EDTA tube. All the samples were centrifuged immediately, the blood being added to the tubes at the side of the centrifuge. The following are the percentage increases in the plasma lead concentrations obtained in the EDTA samples compared with the heparin samples for these six subjects; 370%, 217%, 406%, 176%, 128%, and 323%. This effect was further investigated by following the effect of EDTA on the plasma lead concentration with time. Blood was collected from a subject with blood lead concentration of 35 ,ug/100 ml (1 -69 ,umol/l) and divided into several aliquots, all with EDTA except one, which was collected into heparin in the usual manner. The effect on the plasma lead concentration with time is displayed in fig 4. It can be seen that when EDTA is used it is impossible to separate the plasma from the cells quickly enough to prevent an increase in the plasma lead concentration by a factor of about two. The extent of this increase probably also depends on the exact amount of blood added to the tubes, as variation in the EDTA concentration would affect the elution rate. Chamberlain et al"l have also noted the progressive detachment of 203Pb from the red cells by EDTA in vitro.
As indicated in the introduction, there is no theoretical basis for comparing the plasma lead concentration with the blood lead concentration, and it is considered that the correct approach is to compare the plasma lead concentration with the erythrocyte lead concentration. Although the subjects in part I of this study included many lead workers with excessive exposure to lead, the ones most likely to have experienced erratic lead exposure are the ones with a high erythrocyte lead concentration. The chance, however, of testing many of them within a few hours of a sudden high exposure was small. Nevertheless, this is considered to be the most likely explanation of the higher ratio in the group with erythrocyte lead concentrations greater than 199 ug/100 ml ttmol/l) and also of the four circled points in the scattergram. Two of these four subjects were maintenance men whose exposure to lead is likely to be high but intermittent. One of these two men was known to have cleaned out bag filters a few hours before being tested.
This study provides confirmation for the main conclusions drawn by Cavalleri et all and strongly supports their view that plasma lead concentrations increase progressively throughout the range of blood lead concentrations commonly encountered. Plasma lead concentrations are not maintained within narrow limits as claimed by Rosen et 
Conclusions
The mean equilibrium ratio between plasma lead concentration and erythrocyte lead concentration has been found to be about 074%; but there is considerable individual variation, the standard deviation of the ratio being 031 %. Under conditions of rapid absorption, when the equilibrium is disturbed, the partition ratio increases appreciably, but returns to the equilibrium value in about 24 hours.
Plasma lead concentrations are significantly related to both whole blood lead concentrations and haematocrit. 
